Phase
Condition
Kleptomania
Obsessive-compulsive Disorder
Anxiety Disorders
Treatment
N/AClinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Volunteer subjects with Obsessive Compulsive Disorders (OCD) according to theDiagnostic and Statistical Manual of Mental Disorders (DSM IV-TR) criteria andvalidated by an experimented clinician following instruments like SCID (StructuredClinical Interview for DSM IV) or MINI (Mini-International Neuropsychiatric Interview)
with or without associated tics ("Gilles de la Tourette" Syndrome)
Age > 18 years old
Y-BOCS score > 20 and CGI (Clinical Global Impression Scale) score ≥ 4
Resistant patients to standard treatments - where treatment resistance is defined bypartial but insufficient response (Global Assessment of Functioning score GAF score < 60 and/or reduction of Yale Brown Obsessions and Compulsion Scale score < 35%) or lackof response to previous well conducted treatment including:
pharmacotherapy : optimal tolerated dose and adequate duration (> 12 weeks) of atleast 2 Serotonin Reuptake Inhibitors (selective serotonin reuptake inhibitors,clomipramine), and one augmentation strategy (adjunction of an antipsychotic -such as risperidone or olanzapine or aripiprazole - or lithium or buspirone) ;
psychotherapy (at least 6 months of cognitive and behavioral therapy)
Exclusion
Exclusion Criteria:
other primary diagnosis than OCD (comorbid tics and depression are tolerated)
comorbid diagnosis of schizophrenia/ psychotic disorder, bipolar disorder, substanceabuse or dependance
medical condition involving cognitive decline and affecting brain structures such asParkinson disease, dementia, multiple sclerosis, HIV (human immunodeficiency virus)infection, lupus etc.
Magnetic Resonance Imaging exclusion criteria (ferromagnetic implants etc)
common TMS exclusion criteria (neurological condition with an increased risk ofseizure, cardiac pacemakers, implanted medication pumps, intracardiac lines, or acute,unstable cardiac disease, intracranial implants (e.g. cochlear implants, electrodes,aneurysm clips, stimulators... ) or any other metal object within or near the head,excluding the mouth, that cannot be safely removed will be excluded
Current use of any investigational drug
pregnancy / breast feeding patients
visual or auditive important deficit
Study Design
Study Description
Connect with a study center
CHU de Grenoble - Pavillon Dominique Villars
Grenoble, Rhone Alpes 38000
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.